Little is known about the relationship between genetic recombination mechanisms and loss of tumour suppressor genes in solid tumours. Here, we demonstrate deletion and truncation of both p53 alleles in a primary human glioblastoma and a derived cell line as the combined result of a t(17;20) reciprocal translocation and a 1.1 Mbp genomic deletion on chromosome 17p, starting in intron 4 of the p53 gene and ending at the telomeric CArepeat marker D17S960. These results (i) suggest that genetic instability can lead to loss of tumour suppressor gene function in solid cancers, (ii) provide mapping of one such recombination event at the nucleotide level, and (iii) establish the orientation of the p53 gene on chromosome 17 as: centromere 5' ± 3'-telomere.
Introduction
It is well established that genetic instability is involved in human neoplastic development. Genetic instability encompasses a variety of mechanisms which lead to permanent modi®cation of genomic DNA, possibly creating alterations in oncogenes and tumour suppressor genes and then leading to cancer initiation and/or progression. These changes may be of varying nature, depending on the mechanism involved. Abnormal chromosome (chr.) numbers can occur by a chr. segregation defect (Lengauer et al., 1997) , genomic rearrangements such as chr. loss, translocations and inversions can result from homologous and illegitimate recombination events after double strand DNA breaks (reviewed in Sargent et al., 1997) , whereas smaller alterations at the nucleotide level can result from de®cient mismatch repair giving rise to microsatellite instability (Loeb, 1991; Peltomaki et al., 1993; Bhattacharyya et al., 1994; Wooster et al., 1994; Liu et al., 1995) .
Here, we analysed the sequence of genetic instability events that inactivated the p53 gene in a de novo human glioblastoma (197NE81). Our laboratory has previously shown that the cell line derived from this tumour (LN-308) was tetraploid (Studer et al., 1985) , with cells expressing a truncated mRNA and no detectable protein from the p53 gene (Van Meir et al., 1994a) . p53 is a tumour suppressor gene involved in genetic instability (Yin et al., 1992; Livingstone et al., 1992; Meyn et al., 1994; Bouer et al., 1995; Cross et al., 1995; Fukasawa et al., 1996; Minn et al., 1996; Di Leonardo et al., 1997; Bertrand et al., 1997) , cell cycle arrest, DNA repair and apoptosis (reviewed in Ko and Prives, 1996) . These ®ndings led us to examine: (i) the molecular mechanisms at the origin of this defect (chr. translocation, inversion, deletion, point mutation leading to splice defect or termination codon, allele silencing, etc.), and (ii) the chronological order in which these might have happened. In doing so, we hoped to gain insight into the sequential occurence of genetic instability events during tumour development in relation to the time of p53 alteration.
Results
To examine whether gross genomic rearrangements were involved in the alteration of p53 gene expression in glioblastoma LN-Z308 cell line, we performed uorescent in situ hybridization (FISH) analysis (Lichter et al., 1990) using painting probes for chr. 17 (see Materials and methods). The painting experiment revealed the presence of 5 chromosomes containing chr. 17 sequences ( Figure 1a , and b chr. a ± e), four of these contain a chr. 17 centromere (a, b, d, e), thus demonstrating tetraploidy for this chromosome. Chr. a and b have the gross size and appearance of wild type chr. 17. Chr. d shows the presence of a reciprocal translocation with another chromosome, and chr. e is an isochromosome which seems to derive from two p arms of chr. d. Chr. g lacks a chr.17 centromere and appears to be the translocation partner of chr. d. Preliminary characterization by FISH of the chr. involved in the generation of chr. g, d and e identified it as chr. 20 (data not shown).
To determine whether these translocation events had occurred in the p53 genomic region, thus possibly aecting p53 gene integrity, we performed additional FISH analysis using a combination of p53 cosmid probes and chr. 17 a-satellite probes (Figure 1c and d) . These results con®rmed that four chr. 17 were present in this cell line, and showed that only two of these harbored genomic sequences hybridizing to p53 probes. Gross size evaluation and double labeling with p53 cosmid probes and chr. 17 painting probes (Figure 1e ) identi®ed these as chr. a and b. p53 genomic sequences were not detected on those chr. associated with translocation events (g, d, e) nor on any of the remaining chromosomes (Figure 1c and d) .
Using the polymerase chain reaction (PCR) ( Figure  2 ) and Southern blotting (not shown), we examined whether the p53 sequences found on chr. a and b contained the entire coding region of the p53 gene.
Ampli®cation of individual p53 exons was performed using genomic DNA extracted from LN-Z308. DNA from glioblastoma cell line U87MG which has endogenous wild type p53 alleles (Van Meir et al., 1994a) served as a positive control. Results with PCR and Southern blotting demonstrated that exons 5 ± 11 of the p53 gene were missing in the entire LN-Z308 genome and had thus been lost on chr. a and b.
The retention of exons 1 ± 4 (Figure 2 and data not shown), combined with our FISH results, suggests that chr. a and b contain only a partial p53 gene lacking sequences downstream of exon 4, the possible result of a deletion undetectable in our previous karyotype analyses of these cells (see Materials and methods). To con®rm this hypothesis and examine the sequence adjacent to exon 4 we cloned the junction region by inverse PCR (see Materials and methods). Sequencing of this region showed a chromosome breakpoint 227 bp 3' of exon 4 with fusion to new sequence (Figure 3 ). Database analysis of this sequence identi®ed it as marker D17S960, a Sequenced Tagged Site (STS) containing a CA repeat, located about 1.1 Mbp telomeric to the p53 locus on chr. 17p. All ®ve clones sequenced showed the same junction point, suggesting that chr. a and b carry an identical deletion in the p53 gene.
To establish whether the deletion and translocation events at the origin of p53 alteration arose during cell culture or the in vivo tumorigenic process, we retrieved the original paran-embedded tumour (197NE81) p53 allelic loss through genetic instability in glioblastoma M Albertoni et al from which the LN-Z308 cell line originally derived. Extracted DNA was examined by PCR using primers from each side of the junction. DNA extracted from both biopsy 197NE81 and LN-Z308 cells yielded an ampli®ed product of 337 bp, the size expected given the sequence spanning the deleted area ( Figure 4 ). Two identically-processed glioblastoma biopsies of the same year and three other cell lines failed to amplify any product, showing reaction speci®city. The existence of a reciprocal translocation could not be tested directly on the 197NE81 biopsy. However, our FISH analysis suggested that this event probably occurred prior to genome duplication, since two chromosomes with apparently identical translocation events (d and e) were found (an alternative scenario with translocation occurring after genome duplication involves more steps: a chr. 17 segregation defect and loss of a duplicated wild type chr. 17). Therefore, we reasoned that by demonstrating that genome duplication had occurred in vivo, we could infer that the translocation preceded the duplication event. Sections of 197NE81 biopsy were stained with Feulgen reagent and relative cell¯uorescence was evaluated as a measure of DNA ploidy (see Materials and methods). Sections of normal brain were used as controls to establish relative¯uorescence intensity of diploid cells at an arbitrary DNA index of 1 (Figure 5a ). Tumour sample 197NE81 showed a relative DNA index of 2.03, demonstrating that the majority of cells in this tumour were tetraploid, with a signi®cant number of aneuploid cells. Diploid cells represented tumour microvascular cells and leukocytic in®ltrates. These results suggest that the translocation most likely occurred in vivo.
Discussion
Loss of heterozygosity for chr. 17p occurs frequently in human cancer and usually includes that region encompassing the p53 tumour suppressor gene (17p13.1). P53 allele loss is often associated with point mutations or small deletions of the remaining p53 allele (Nigro et al., 1989) . In certain tumour types, such as osteosarcomas and lung cancers, the remaining p53 allele is frequently lost by gene rearrangement (reviewed in Miller et al., 1990) . The rate at which this occurs in other cancer types is lower; however, this may have been underestimated in instances when PCR and sequencing alone were used to determine p53 status due to the presence of non-tumoral cells. The mapping of these deletions at the nucleotide level has not been performed, nor has it been determined whether chr. 17p loss and p53 gene alterations occur in a de®ned order during tumorigenesis.
In glioblastoma, mutated forms of the p53 gene are found in about 30% of tumours, in a region corresponding to the DNA binding domain of the protein (von Deimling et al., 1992) . We showed that this percentage is much higher in cell lines (&70%), with 30% retaining a functional wild type p53 protein (Van Meir et al., 1994a) . In one cell line (LN-Z308) a small truncated p53 mRNA and no detectable protein were found, supporting its use in studies analysing p53 function by gene transfer (Van Meir et al., 1994b . Here, we have demonstrated that two independent genetic instability events (intrachromosomal deletion and interchromosomal translocation) altered the tumour suppressor gene p53 in these cells. The tetraploid genome of LN-Z308 contains four chr. 17, two of these have an identical 1.1 Mbp. deletion comprising a portion of the p53 gene and two have lost the entire p53 locus as a consequence of a t(17;20) reciprocal translocation. Precise junction mapping of the 1.1 Mbp. deletion showed that it starts in intron 4 of the p53 gene and ends in the telomeric CA-repeat marker D17S960 on chr. 17. PCR analysis on DNA of the glioblastoma from which this cell line derives showed that this genomic re-arrangement was already present in the original tumour, thus excluding the possibility it arose in cell culture. Figure 6 proposes an order by which these genomic rearrangements may have occurred assuming a minimal amount of events. In this model p53 alterations result from genetic instability events. While alternative scenarios remain possible, these would involve additional genetic instability steps such as multiple chr. segregation problems, deletions, translocations and/or cell fusions. It is unlikely that p53 gene inactivation (as a result of point mutation or by epigenetic silencing) initiated the genetic instability in these cells, for then the elimination of these very same alleles by deletion or translocation would appear unnecessary, and therefore, unlikely. In addition, though some tumour suppressor genes such as HIC-1 or p16, may be inactivated by methylation (Makos-Wales et al., 1995; Merlo et al.,
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197 NE 81 1 NE 81 128 NE 81 -337 bp Figure 4 PCR ampli®cation of the DNA fragment spanning the deletion junction point using primers p53in4F and D17S960R2 (see Materials and methods). In cells where the deletion is absent, the distance between primers is about 1.1 Mbp, so no ampli®cation product is expected 1995), this has not been reported for p53. Hypomethylation can, however, lead to genome-wide double strand DNA breaks, including the p53 gene (Pogribny et al., 1995) . The model presented in Figure 6 is consistent with p53 gene loss due to the operation of some genetic instability process(es) controlled by genes other than p53. This supports recent data showing that defects in chr. segregation, a form of genetic instability, can precede mutation of the p53 gene (Lengauer et al., 1997 Leonardo et al., 1997) . A correlation between wild type p53 status and genome diploidy was also shown in 14 low grade astrocytoma (van Meyel et al., 1994) . Other forms of genetic instability, such as ampli®cation and gene conversion, have been shown to be controlled by p53, perhaps due to WTp53's capacity to bind to RAD51, a key factor in homologous recombination and/or recombinatorial DNA repair (Livingstone et al., 1992; Yin et al., 1992; Bouer et al., 1995; Bertrand et al., 1997) . Remarkably, LN-Z308 cells reached a new genetic balance after undergoing these events, since few dierences in karyotype were seen between 1982 and 1993, a period comprising more than 65 passages (see Materials and methods). These types of analyses improve our understanding of the genetic recombination mechanisms inducing loss of tumour suppressor genes and leading to cancer. The determination of the speci®c DNA sequences involved in these events should yield insights into the mechanistic processes of homologous and illegitimate recombinations. Our ®nding that the deletion occured in the vicinity of a CA repeat suggests that further studies should examine whether DNA regions with such motifs are structurally vulnerable to double strand breaks. Furthermore, these results established the orientation of the p53 gene on chr. 17, with the 5' end located proximally and the 3' end distally to the centromere. Finally, the ®nding of p53-null glioblastoma suggests that the true frequency of p53 inactivation in glioblastoma may have been underestimated due to false wild type p53 diagnosis by PCR on clinical samples containing non-neoplastic cells.
Materials and methods

Cell culture
The glioblastoma cell lines LN-Z308, U87MG, T98G and G130, astrocytoma cell line LN-319 and osteosarcoma cell line Saos-2 were cultured as previously described (Van Meir et al., 1994a) . These cells were routinely examined for mycoplasma contamination and found to be consistently negative. LN-Z308 is a subculture of the original LN-308 cell line established from a glioblastoma patient in Lausanne in 1981 (Studer et al., 1985) that was cultured independently in ZuÈ rich from 1982 to 1990. Analysis of LN-Z308 karyotype in 1993 showed the following karyotype: 70 ± 8354n4, X, 7X, 7Y, 7Y, +hsr(1) (q+), 72, 73, 74, del(4)(q25), 75, 76, +7, 78, 79, 79, 710, 711, 711, 711, 712, 713, 713, 714, 714, 715, 716, 717, 717, add(17)(p12), 718, 718, 720, 720, del(20)(q12), 721, 722, 722, +mar2, +mar4, +mar5, +mar6[cp10] . This karyotype is similar to the one established for LN-308 in 1984 (Studer et al., 1985) , thus showing the common origin and long term overall chr. stability of these cells. Fluorescent activated cell sorter analysis of LN-Z308 cells in 1993 with an anti-a human MHC class I antibody (Pharmingen, San Diego) con®rmed the human origin of the cells (R Nishikawa and EGVM, unpublished results).
Paran embedded brain biopsies
Biopsy 197NE81 corresponds to the de novo glioblastoma from which cell line LN-Z308 was derived. Biopsy 114NE82 is a fragment of normal brain cortex. Two other glioblastoma biopsies from 1981 were used as controls (1NE81 and 128NE81). Figure 6 Model for the sequential loss of p53 alleles in glioblastoma 197NE81. Greek letters indicate chromosomes identi®ed by FISH analysis in Figure 1 p53 allelic loss through genetic instability in glioblastoma M Albertoni et al
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DNA extraction
Cells were trypsinized and cell membranes lysed in TritonLysis Buer (320 mM Sucrose, 10 mM Tris-HCl pH7.5, 5 mM MgCl 2 , 1% Triton X100) for 10 min. at 48C. Cell nuclei were recovered from the lysate by centrifugation at 650 g at 48C for 15 min and subsequently lysed in NucleiLysis Buer (75 mM NaCl, 24 mM EDTA pH 8.0), with Proteinase K (0.8 g/l) and 1% Sarkosyl during 1 h at 508C. Nucleic acids were separted from proteins by two extractions with buer-saturated phenol followed by two extractions with phenol: chloroform: isoamylalcohol (25 : 24 : 1). Genomic DNA was precipitated with half volume of 7.5 M ammonium acetate and one volume of isopropanol at room temperature, DNA drawn, washed in 70% EtOH and resuspended in TE 74 buer (10 mM TrisHCl pH 8.0, 0.1 mM EDTA pH 8.0) by gently shaking overnight. A second precipitation was performed with 0.1 volume of 3 M NaOAc and 2.5 volumes of EtOH 100%. DNA was washed and resuspended in TE 74 buer. For DNA extraction from paran embedded biopsies, six to eight 6 mm sections were prepared and excess paran removed. The sections were washed with ethanol and centrifuged. DNA extraction was performed using an EX-WAX 2 DNA extraction kit (Oncor). DNA was recovered in 50 ml ®nal volume.
Polymerase chain reaction (PCR)
PCR reactions were performed in 50 ml ®nal volume, containing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 1.5 mM MgCl 2 , 0.1 mM of each dNTP, 1 mM of each primers and 1.5 U Taq DNA polymerase. 250 ng of genomic DNA from cell lines or 2.5 ml DNA extracted with the EX-WAX 2 Kit were used as template. PCR was performed for 5 min at 958C, followed by 35 ± 40 cycles of ampli®cation at the following times and temperatures: 1 min. at 948C, 40 s at the melting temperature (Tm), 30 s to 1 min at 728C. Ampli®ed DNA was analysed by nondenaturing agarose gel electrophoresis. Primers used for exon's DNA ampli®cation and deletion junction point analysis are described in Table 1 .
Inverse PCR
Inverse PCR was performed as previously described (McPherson et al., 1991) . Five mg of genomic DNA were digested with AvaII or BfaI and circularized using T4 DNA ligase (Gibco BRL). Ligated DNA was then precipitated and linearized with XcmI. 250 ng of DNA from each step were used for nested PCR. Primers p53x4C
(5'-GGCATTCTGGGAGCTTCA-3') and p53x4D (5'-AC-CTACCAGGGCAGCTAC-3') were used in the ®rst PCR (25 cycles) using 578C as Tm. 5 ml of this ampli®cation were added to the second PCR mixture containing primers p53x4C and p53x4E (5'-GCATTCTGGGACAGCCAA-3'). The samples were subjected to an additional 25 cycles of ampli®cation using 598C as Tm. One tenth of PCR products were submitted to 10 cycles with pfu DNA polymerase to generate blunt ends, ligated into the EcoRV site of pBluescript SK vector (Stratagene) and transformed in XL1-blue bacteria. Sequencing was performed on 3 of 11 AvaII and 2 of 7 BfaI-derived inverse PCR clones with Sequenase 2 Version 2.0 DNA sequencing Kit (United States Biochemicals) and products were electrophoresed on a 6% denaturing polyacrylamide gel.
Ploidy analysis
Biopsies 197NE81 (tumour) and 114NE82 (normal brain as diploid control) were ®xed in 10% buered formalin and paran-embedded by standard methods. Feulgen reaction on 6 mm sections were used to determine DNA content by image cytometry (Marchevsky et al., 1996) . 137 and 26 well-preserved non-overlapping cell nuclei were evaluated for 197NE81 and 114NE82, respectively. Optical density and integrated optical density (IOD) were calculated for each nucleus. Histograms were obtained by assigning classes with a computer IOD range and by taking into account both the number of nuclei and the total range of values measured in both cases. The histograms were interpreted and classi®ed by assigning a DNA index (DI)=1 to diploid cells, DI=2 to tetraploid cells and so on as previously described (Luzi et al., 1994) .
FISH
Fluorescence in situ hybridization (FISH) (Lichter et al., 1990) was performed on metaphase chromosome preparations of LN-Z308 cells as previously described (Bermingham et al., 1995) . The chr. 17 painting and a-satellite probes, and p53 cosmid probes were used according to the manufacturer's instructions (Oncor, Gaithersburg, MD). p53 cosmid probes were shown to contain sequences for p53 exons 4 and 11 by Southern blotting (MA and EGVM, unpublished results).
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